Lee B. Perry
Keine laufenden Positionen mehr
Profil
Lee B.
Perry worked as a Senior Finance Director at Questcor Pharmaceuticals, Inc. from 2002 to 2005, as a Finance Director at DNA Sciences, Inc. from 1999 to 2002, and as the Chief Accounting Officer & Vice President at VIVUS, Inc. from 2005 to 2013.
He also worked as the Chief Financial Officer at BHP Coated Steel Corp.
Mr. Perry received an undergraduate degree from San Diego State University.
Ehemalige bekannte Positionen von Lee B. Perry
Unternehmen | Position | Ende |
---|---|---|
VIVUS, INC. | Comptroller/Controller/Auditor | 31.12.2013 |
QUESTCOR PHARMACEUTICALS INC | Finanzdirektor/CFO | 01.03.2005 |
DNA Sciences, Inc.
DNA Sciences, Inc. Medical SpecialtiesHealth Technology Part of AbbVie, Inc., DNA Sciences, Inc. is a company that develops and produces in vitro diagnostic and research reagent products. The company is based in Fremont, CA. The company was founded by Hugh Young Rienhoff. DNA Sciences was acquired by Genaissance Pharmaceuticals, Inc., part of AbbVie, Inc. from October 07, 2005 on April 01, 2003 for $1.30 million. | Finanzdirektor/CFO | 01.05.2002 |
BHP Coated Steel Corp
BHP Coated Steel Corp SteelNon-Energy Minerals Part of Ternium SA, BHP Coated Steel Corp produces cold-rolled, metallic-coated and custom-painted steel coils for the construction and OEM markets. The company is based in Kalama, WA. BHP Coated Steel was acquired by IMSA Acero SA de CV on May 25, 2000 for $234 million. | Finanzdirektor/CFO | - |
Ausbildung von Lee B. Perry
San Diego State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
VIVUS, Inc.
VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
Questcor Pharmaceuticals, Inc.
Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA. | Health Technology |
DNA Sciences, Inc.
DNA Sciences, Inc. Medical SpecialtiesHealth Technology Part of AbbVie, Inc., DNA Sciences, Inc. is a company that develops and produces in vitro diagnostic and research reagent products. The company is based in Fremont, CA. The company was founded by Hugh Young Rienhoff. DNA Sciences was acquired by Genaissance Pharmaceuticals, Inc., part of AbbVie, Inc. from October 07, 2005 on April 01, 2003 for $1.30 million. | Health Technology |
BHP Coated Steel Corp
BHP Coated Steel Corp SteelNon-Energy Minerals Part of Ternium SA, BHP Coated Steel Corp produces cold-rolled, metallic-coated and custom-painted steel coils for the construction and OEM markets. The company is based in Kalama, WA. BHP Coated Steel was acquired by IMSA Acero SA de CV on May 25, 2000 for $234 million. | Non-Energy Minerals |